ReviewEuropean journal of medical research2024
Analysis of risk factors for benign central airway stenosis after COVID-19 infection.
Review in European journal of medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate the risk factors associated with benign central airway stenosis following COVID-19 infection.
methodsThe clinical data of 235 patients hospitalized for COVID-19 infection at the First Affiliated Hospital of Zhengzhou University from October 2022 to October 2023 were retrospectively analyzed. Based on the occurrence of postoperative central airway stenosis, the patients were categorized into a stenosis group (118 cases) and a control group (117 cases). The incidence of central airway stenosis following COVID-19 infection was summarized. Univariate and multivariate logistic regression analyses were conducted to identify risk factors associated with central airway stenosis after COVID-19 infection.
resultsAmong the 235 patients studied, 118 developed central airway stenosis. The results of the univariate analysis indicated that age, sex, liver function (as measured by alanine aminotransferase and aspartate aminotransferase values), renal function (creatinine values), diabetes mellitus, fungal airway infections, tuberculosis, and nutritional status (albumin values) were identified as risk factors for benign central airway stenosis following COVID-19 infection (P < 0.05). Furthermore, the multivariate analysis revealed that sex, diabetes mellitus, fungal airway infections, tuberculosis, and nutritional status (albumin values) were independent risk factors for benign central airway stenosis after COVID-19 infection (all P < 0.05).
conclusiondiabetes mellitus, fungal airway infections, tuberculosis, and poor nutritional status may lead to benign central airway stenosis after COVID-19 infection. Proactive preventive measures and close monitoring should be taken to improve the quality of life of patients infected with COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.